Apotheek Bollen-Tack SRL

Apotheek Bollen-Tack reported total assets of 523,501 € at the end of the 2025 financial year (annual accounts filed with the NBB on 16 Jul 2026).

Company number (CBE) 0467.029.462 · VAT BE0467029462
3300 Tienen
active in Retail sale of pharmaceutical products (NACE 47730)
operating since 11 Oct 1999 (≈ 27 yrs)
Public Public page: latest year only. The score, history and details open with a free account. Create a free account
Idonis solidity score
EDCBA

The score of Apotheek Bollen-Tack shows with a free account.

See the score
Profile
SRL since 1999
Components
  • Summary? / 5
    • Balance sheet strength
    • Liquidity
    • Repayment capacity
    • Profitability
    • Trajectory
    • Compliance and register
  • Position in its sectorvs peers
  • Supplier creditat 30 d
  • Borrowing capacityborrowable
  • Valuationcentral

Visible once signed in: create your account, the 14-day Pro trial is free.

Detail

Key figures 2025

Net result172,571 €
Equity30,877 €
Cash106,309 €
EBITDA208,519 €
Total assets523,501 €
Solvency5.9%
The line marks its sector median: 44.2% (2068 companies).

Change 2022 → 2025: Equity +8 % Total assets +9 %

Accounts of the company itself (not consolidated).

The full file covers 10 financial years; a free account shows 2. →

Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error

Apotheek Bollen-Tack's annual accounts

20252024202320222021
Net result172,571 €
Equity30,877 €
Cash106,309 €
EBITDA208,519 €
Total assets523,501 €

Filed annual accounts

  • Year ended 31 Dec 2025filed on 16 Jul 2026
  • Year ended 31 Dec 2024filed on 23 May 2025
  • Year ended 31 Dec 2023filed on 18 Jun 2024
  • Year ended 31 Dec 2022filed on 18 Aug 2023
  • Year ended 31 Dec 2021filed on 23 May 2022

Apotheek Bollen-Tack's financial analysis

Management and control of Apotheek Bollen-Tack

2 active director(s) in the register.

Apotheek Bollen-Tack's shareholders and holdings →

Apotheek Bollen-Tack's publications in the Belgian Gazette

Company number, VAT number and registered office

Company number (CBE)
0467.029.462
VAT number
BE0467029462
Peppol
Registered · 0208:0467029462 · as of 10 Nov 2026
Legal form
SRL
Incorporated
11 Oct 1999
Registered office
3300 Tienen
Latest accounts
2025 · filed on 16 Jul 2026
Activity
Retail sale of pharmaceutical products (NACE 47730)

Apotheek Bollen-Tack (SRL) has been based in Tienen since 1999, active in: retail sale of pharmaceutical products. For 2025, it reports a net profit of 172,571 € and equity of 30,877 €; its revenue is not published. Its solvency stands at 5.9%, below the median of its sector (44.2%).

Companies similar to Apotheek Bollen-Tack

Companies in the same business, of comparable size and area, outside its group.

Frequently asked questions about Apotheek Bollen-Tack

What is the revenue of Apotheek Bollen-Tack?

Apotheek Bollen-Tack files its accounts in a format where revenue is optional: it is not published for 2025.

What is the VAT number of Apotheek Bollen-Tack?

In Belgium, the VAT number is the company number prefixed with BE: BE0467029462 for Apotheek Bollen-Tack, if the company is VAT-registered. Its company number (CBE) is 0467.029.462.

Where is the registered office of Apotheek Bollen-Tack?

According to the CBE register, the registered office of Apotheek Bollen-Tack is in 3300 Tienen.

What is the equity of Apotheek Bollen-Tack?

At the close of the 2025 financial year, the equity of Apotheek Bollen-Tack amounts to 30,877 €, a solvency of 5.9% of total assets.

Who manages Apotheek Bollen-Tack?

The register lists 2 active mandates at Apotheek Bollen-Tack. Names and roles are in the full file, with the deeds published in the Belgian Gazette.

Idonis

The full file of Apotheek Bollen-Tack

Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.

Open the full file →
Free account in 30 seconds, by email. No bank card.
Sources : Annual accounts — NBB ↗ Register — CBE ↗ Deeds — Belgian Gazette ↗

No credit card, no commitment.

What each plan unlocks →